Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognition Disorders | 15 | 2018 | 390 | 2.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 24 | 2020 | 1523 | 1.970 |
Why?
|
| Brain | 18 | 2018 | 1031 | 1.820 |
Why?
|
| Cognition | 13 | 2020 | 576 | 1.440 |
Why?
|
| Aging | 8 | 2015 | 1010 | 1.360 |
Why?
|
| Auditory Perception | 8 | 2009 | 80 | 1.070 |
Why?
|
| Attention | 6 | 2009 | 91 | 1.000 |
Why?
|
| Magnetic Resonance Imaging | 16 | 2018 | 1387 | 0.880 |
Why?
|
| Visual Perception | 7 | 2009 | 122 | 0.770 |
Why?
|
| Caloric Restriction | 2 | 2019 | 122 | 0.680 |
Why?
|
| Neuropsychological Tests | 12 | 2019 | 372 | 0.580 |
Why?
|
| Aged | 30 | 2020 | 11002 | 0.540 |
Why?
|
| Obesity | 3 | 2019 | 1246 | 0.520 |
Why?
|
| Exercise | 2 | 2019 | 701 | 0.510 |
Why?
|
| Exercise Therapy | 1 | 2019 | 283 | 0.500 |
Why?
|
| Female | 35 | 2020 | 21499 | 0.420 |
Why?
|
| Diabetic Retinopathy | 1 | 2014 | 72 | 0.410 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2013 | 3 | 0.410 |
Why?
|
| Humans | 41 | 2020 | 34497 | 0.410 |
Why?
|
| Cerebrovascular Disorders | 1 | 2013 | 55 | 0.390 |
Why?
|
| Pain | 1 | 2015 | 330 | 0.380 |
Why?
|
| Middle Aged | 26 | 2020 | 12707 | 0.380 |
Why?
|
| Mobility Limitation | 1 | 2014 | 222 | 0.370 |
Why?
|
| African Americans | 8 | 2018 | 1435 | 0.360 |
Why?
|
| Male | 30 | 2019 | 20713 | 0.360 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2012 | 35 | 0.350 |
Why?
|
| Adult | 19 | 2016 | 10019 | 0.350 |
Why?
|
| Cerebral Cortex | 2 | 2009 | 146 | 0.340 |
Why?
|
| Coronary Artery Disease | 2 | 2015 | 441 | 0.320 |
Why?
|
| Alzheimer Disease | 1 | 2013 | 295 | 0.320 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2007 | 115 | 0.300 |
Why?
|
| Sensation | 1 | 2009 | 60 | 0.290 |
Why?
|
| Acoustic Stimulation | 7 | 2009 | 122 | 0.280 |
Why?
|
| Dementia | 3 | 2015 | 253 | 0.280 |
Why?
|
| Cues | 4 | 2009 | 65 | 0.280 |
Why?
|
| Photic Stimulation | 7 | 2009 | 172 | 0.280 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2017 | 302 | 0.280 |
Why?
|
| Brain Mapping | 5 | 2014 | 208 | 0.260 |
Why?
|
| Biomedical Research | 1 | 2008 | 186 | 0.250 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2007 | 137 | 0.250 |
Why?
|
| Risk Factors | 8 | 2018 | 4136 | 0.210 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2015 | 222 | 0.210 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2016 | 1078 | 0.190 |
Why?
|
| Genotype | 3 | 2020 | 743 | 0.190 |
Why?
|
| Genome-Wide Association Study | 2 | 2016 | 555 | 0.190 |
Why?
|
| European Continental Ancestry Group | 6 | 2018 | 1176 | 0.190 |
Why?
|
| Cross-Sectional Studies | 6 | 2018 | 1607 | 0.190 |
Why?
|
| Reaction Time | 5 | 2009 | 131 | 0.190 |
Why?
|
| Brain Diseases | 2 | 2014 | 39 | 0.190 |
Why?
|
| Organ Size | 5 | 2018 | 236 | 0.190 |
Why?
|
| Albuminuria | 4 | 2017 | 181 | 0.180 |
Why?
|
| Aged, 80 and over | 10 | 2016 | 4152 | 0.170 |
Why?
|
| Life Style | 2 | 2020 | 418 | 0.160 |
Why?
|
| Genetic Association Studies | 3 | 2016 | 149 | 0.160 |
Why?
|
| Models, Neurological | 2 | 2014 | 145 | 0.160 |
Why?
|
| Diabetes Complications | 3 | 2018 | 189 | 0.160 |
Why?
|
| Apolipoprotein E4 | 1 | 2020 | 59 | 0.160 |
Why?
|
| Auditory Cortex | 3 | 2009 | 21 | 0.160 |
Why?
|
| Cohort Studies | 7 | 2018 | 1910 | 0.150 |
Why?
|
| Analysis of Variance | 3 | 2009 | 508 | 0.150 |
Why?
|
| Blood Glucose | 3 | 2019 | 529 | 0.150 |
Why?
|
| Executive Function | 1 | 2019 | 60 | 0.150 |
Why?
|
| Menopause | 1 | 2020 | 111 | 0.150 |
Why?
|
| Task Performance and Analysis | 2 | 2009 | 54 | 0.150 |
Why?
|
| Cardiovascular Diseases | 3 | 2017 | 1209 | 0.150 |
Why?
|
| Estrogens, Conjugated (USP) | 2 | 2015 | 159 | 0.130 |
Why?
|
| Sex Characteristics | 1 | 2018 | 182 | 0.130 |
Why?
|
| Weight Loss | 1 | 2020 | 494 | 0.120 |
Why?
|
| Apolipoproteins E | 1 | 2016 | 91 | 0.120 |
Why?
|
| Postmenopause | 2 | 2015 | 461 | 0.120 |
Why?
|
| Overweight | 1 | 2018 | 289 | 0.120 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 1 | 2016 | 4 | 0.120 |
Why?
|
| Young Adult | 3 | 2014 | 2827 | 0.120 |
Why?
|
| Spectrin | 1 | 2014 | 5 | 0.110 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 12 | 0.110 |
Why?
|
| Vascular Diseases | 1 | 2015 | 69 | 0.110 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2014 | 56 | 0.110 |
Why?
|
| Prevalence | 2 | 2018 | 1034 | 0.110 |
Why?
|
| Arachidonic Acid | 2 | 2011 | 41 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2014 | 849 | 0.110 |
Why?
|
| Glomerular Filtration Rate | 4 | 2017 | 315 | 0.110 |
Why?
|
| Anxiety | 1 | 2015 | 206 | 0.100 |
Why?
|
| Dopamine | 1 | 2016 | 268 | 0.100 |
Why?
|
| Cerebrovascular Circulation | 2 | 2015 | 104 | 0.100 |
Why?
|
| Tomography, Spiral Computed | 1 | 2013 | 21 | 0.100 |
Why?
|
| Diabetic Nephropathies | 1 | 2014 | 228 | 0.100 |
Why?
|
| Nerve Net | 1 | 2014 | 141 | 0.090 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 801 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2016 | 765 | 0.090 |
Why?
|
| Depression | 1 | 2015 | 458 | 0.090 |
Why?
|
| Visual Cortex | 2 | 2009 | 47 | 0.090 |
Why?
|
| Heart Ventricles | 1 | 2013 | 155 | 0.090 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2011 | 15 | 0.090 |
Why?
|
| United States | 6 | 2018 | 4267 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2019 | 3618 | 0.090 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2011 | 36 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2011 | 45 | 0.090 |
Why?
|
| Proportional Hazards Models | 2 | 2013 | 803 | 0.080 |
Why?
|
| Fatty Acid Desaturases | 1 | 2011 | 51 | 0.080 |
Why?
|
| Computational Biology | 1 | 2011 | 100 | 0.080 |
Why?
|
| Prognosis | 1 | 2014 | 1603 | 0.080 |
Why?
|
| Science | 1 | 2010 | 8 | 0.080 |
Why?
|
| Social Responsibility | 1 | 2010 | 14 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 548 | 0.080 |
Why?
|
| Ethics, Research | 1 | 2010 | 25 | 0.080 |
Why?
|
| Research | 1 | 2010 | 88 | 0.080 |
Why?
|
| Teaching | 1 | 2010 | 65 | 0.080 |
Why?
|
| Fixation, Ocular | 1 | 2009 | 6 | 0.080 |
Why?
|
| Noise | 1 | 2009 | 7 | 0.080 |
Why?
|
| Stroke Volume | 1 | 2013 | 440 | 0.070 |
Why?
|
| Space Perception | 1 | 2009 | 30 | 0.070 |
Why?
|
| Environment | 1 | 2009 | 51 | 0.070 |
Why?
|
| Perceptual Disorders | 1 | 2009 | 8 | 0.070 |
Why?
|
| Laboratories | 1 | 2008 | 18 | 0.070 |
Why?
|
| Behavior | 1 | 2008 | 31 | 0.070 |
Why?
|
| Heterozygote | 2 | 2020 | 66 | 0.070 |
Why?
|
| Curriculum | 1 | 2010 | 217 | 0.070 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 116 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 259 | 0.070 |
Why?
|
| Sensory Thresholds | 1 | 2007 | 30 | 0.070 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2007 | 5 | 0.070 |
Why?
|
| Echo-Planar Imaging | 1 | 2007 | 15 | 0.070 |
Why?
|
| Mental Processes | 1 | 2007 | 16 | 0.070 |
Why?
|
| Adolescent | 4 | 2009 | 3801 | 0.070 |
Why?
|
| Perception | 1 | 2007 | 107 | 0.060 |
Why?
|
| Age Factors | 1 | 2009 | 1262 | 0.060 |
Why?
|
| Creatinine | 2 | 2017 | 206 | 0.060 |
Why?
|
| Diabetic Angiopathies | 2 | 2015 | 153 | 0.050 |
Why?
|
| Linear Models | 2 | 2017 | 464 | 0.050 |
Why?
|
| Kidney Function Tests | 2 | 2015 | 107 | 0.050 |
Why?
|
| Hypertension | 3 | 2017 | 1024 | 0.050 |
Why?
|
| Risk | 2 | 2015 | 325 | 0.050 |
Why?
|
| Animals | 1 | 2015 | 8544 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2015 | 565 | 0.050 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 2 | 2011 | 14 | 0.040 |
Why?
|
| Gene Frequency | 2 | 2011 | 222 | 0.040 |
Why?
|
| Fatigue | 1 | 2019 | 90 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2019 | 167 | 0.040 |
Why?
|
| Exercise Test | 1 | 2019 | 247 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2019 | 262 | 0.030 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 140 | 0.030 |
Why?
|
| Behavior Therapy | 1 | 2018 | 107 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2017 | 185 | 0.030 |
Why?
|
| Minisatellite Repeats | 1 | 2016 | 9 | 0.030 |
Why?
|
| Pedigree | 1 | 2016 | 142 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2019 | 954 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 703 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 96 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2015 | 79 | 0.030 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2015 | 115 | 0.030 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2016 | 112 | 0.030 |
Why?
|
| Stroop Test | 1 | 2014 | 5 | 0.030 |
Why?
|
| Memory | 1 | 2016 | 216 | 0.030 |
Why?
|
| Time Factors | 1 | 2020 | 2352 | 0.030 |
Why?
|
| Albumins | 1 | 2014 | 47 | 0.030 |
Why?
|
| Atrophy | 1 | 2014 | 51 | 0.030 |
Why?
|
| Glucose | 1 | 2015 | 194 | 0.030 |
Why?
|
| Estrogens | 1 | 2015 | 210 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2014 | 124 | 0.020 |
Why?
|
| Educational Status | 1 | 2014 | 185 | 0.020 |
Why?
|
| Smoking | 1 | 2017 | 544 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 924 | 0.020 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2013 | 18 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 656 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 176 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 1289 | 0.020 |
Why?
|
| Siblings | 1 | 2011 | 24 | 0.020 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2011 | 32 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2011 | 26 | 0.020 |
Why?
|
| Multigene Family | 1 | 2011 | 54 | 0.020 |
Why?
|
| Family Health | 1 | 2011 | 79 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2011 | 189 | 0.020 |
Why?
|
| North Carolina | 1 | 2015 | 1612 | 0.020 |
Why?
|
| Education, Graduate | 1 | 2010 | 4 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 934 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2366 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2008 | 66 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2013 | 657 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2008 | 310 | 0.020 |
Why?
|
| Color Perception | 1 | 2007 | 2 | 0.020 |
Why?
|
| Sample Size | 1 | 2007 | 40 | 0.020 |
Why?
|
| Reference Values | 1 | 2007 | 265 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 123 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2007 | 256 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2007 | 193 | 0.010 |
Why?
|